DISORDERS OF PHOSPHATE METABOLISM

Baldursson, 1969, Tumoral calcinosis with hyperphosphatemia: A report of a family with incidence in four siblings, J Bone Joint Surg, 51-A, 913, 10.2106/00004623-196951050-00008 Beck, 1998, Targeted inactivation of NPT2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities, Proc Natl Acad Sci USA, 95, 5372, 10.1073/pnas.95.9.5372 Beck, 1997, Pex/PEX tissue distribution and evidence for a deletion in the 3′ region of the Pex gene in X-linked hypophosphatemic mice, J Clin Invest, 99, 1200, 10.1172/JCI119276 Bianchine, 1971, Familial hypophosphatemic rickets showing autosomal dominant inheritance, Birth Defects: Original Article Series, 7, 287 Blydt-Hansen, 1999, PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia, Pediatr Nephrol, 13, 607, 10.1007/s004670050669 Bradbury, 1987, Neurological involvement in X-linked hypophosphatemic rickets, J Neurol Neurosurg Psychiatr, 50, 810, 10.1136/jnnp.50.6.810 Cai, 1994, Brief report: Inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia, N Engl J Med, 330, 1645, 10.1056/NEJM199406093302304 Cameron, 1999, A trial of growth hormone therapy in well-controlled hypophosphatemic rickets, Clin Endocrinol, 50, 577, 10.1046/j.1365-2265.1999.00680.x Carpenter, 1996, 24,25-Dihydroxyvitamin D supplementation corrects hyperparathyroidism and improves skeletal abnormalities in X-linked hypophosphatemic rickets—a clinical research study, J Clin Endocrinol Metab, 81, 2381, 10.1210/jc.81.6.2381 Chalew, 1996, Hypophosphatemia induced in mice by transplantation of a tumor-derived cell line from a patient with oncogenic rickets, J Pediatr Endocrinol Metab, 9, 593, 10.1515/JPEM.1996.9.6.593 Chausmer, 1982, Phosphate depletion therapy in two ectopic calcification syndromes, J Am Coll Nutr, 1, 275, 10.1080/07315724.1982.10718996 Chen, 1989, Hypercalciuric hypophosphatemic rickets, mineral balance, bone histomorphometry, and therapeutic implications of hypercalciuria, Pediatrics, 84, 276 Chong, 1995, Cloning, genetic mapping, and expression analysis of a mouse renal sodium-dependent phosphate cotransporter, Am J Physiol, 268, F1038 Coleman, 1954, Craniostenosis with familial vitamin D–resistant rickets, BMJ, 1, 561, 10.1136/bmj.1.4861.561 Davies, 1981, The rheumatic manifestations of metabolic bone disease, Clinics in Rheumatic Diseases, 7, 595, 10.1016/S0307-742X(21)00372-6 Du, 1996, cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone, Genomics, 36, 22, 10.1006/geno.1996.0421 Dubois, 1999, Evidence that a neutral endopeptidase-like activity of the Hyp mouse osteoblasts is responsible for the elaboration of the inhibitor of phosphate uptake by renal cells [abstract], J Bone Miner Res, 14, S224 Ecarot, 1995, Effect of 1,25-dihydroxyvitamin D3 treatment on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice, J Bone Miner Res, 10, 424, 10.1002/jbmr.5650100313 Ecarot-Charrier, 1988, Defective bone formation by transplanted Hyp mouse bone cells into normal mice, Endocrinology, 123, 768, 10.1210/endo-123-2-768 Econs, 1992, Bone disease resulting from inherited disorders of renal tubule transport and vitamin D metabolism, 935 Econs, 1994, Tumor-induced osteomalacia—unveiling a new hormone, N Engl J Med, 330, 1679, 10.1056/NEJM199406093302310 Econs, 1991, X-linked hypophosphatemic rickets without “rickets.”, Skeletal Radiology, 20, 109, 10.1007/BF00193821 Econs, 1997, Autosomal dominant hypophosphatemic rickets/osteomalacia: Clinical characterization of a novel renal phosphate wasting disorder, J Clin Endocrinol Metab, 82, 674, 10.1210/jc.82.2.674 Econs, 1997, Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13, J Clin Invest, 100, 2653, 10.1172/JCI119809 Econs, 1994, X-linked hypophosphatemic rickets: A disease often unknown to affected patients, J Bone Miner Res, 24, 17, 10.1016/S0169-6009(08)80127-4 Eicher, 1976, Hypophosphatemia: Mouse model for human familial hypophosphatemic (vitamin D–resistant) rickets, Proc Natl Acad Sci USA, 73, 4667, 10.1073/pnas.73.12.4667 Filisetti, 1999, Nonrandom distribution of mutations in the PHEX gene, and underdetected missense mutations at nonconserved residues, Eur J Hum Genet, 7, 615, 10.1038/sj.ejhg.5200341 Francis, 1997, Genomic organization of the human PEX gene mutated in X-linked dominant hypophosphatemic rickets, Genome Res, 7, 573, 10.1101/gr.7.6.573 Gazit, 1991, Osteomalacia in hereditary hypophosphatemic rickets with hypercalciuria: A correlative clinical-histomorphometric study, J Clin Endocrinol Metab, 72, 229, 10.1210/jcem-72-1-229 Greenberg, 1960, The normal range of serum inorganic phosphorus and its utility as a discriminant in the diagnosis in congenital hypophosphatemia, J Clin Endocrinol Metab, 20, 364, 10.1210/jcem-20-3-364 Grieff, 1997, Expression and cloning of the human X-linked hypophosphatemia gene cDNA, Biochem Biophys Res Commun, 231, 635, 10.1006/bbrc.1997.6153 Hanna, 1991, X-linked hypophosphatemia: Genetic and clinical correlates, Am J Dis Child, 145, 865, 10.1001/archpedi.1991.02160080041018 Hardy, 1989, X-linked hypophosphatemia in adults: Prevalence of skeletal radiographic and scintigraphic features, Radiology, 171, 403, 10.1148/radiology.171.2.2539609 Harrison, 1979, Rickets and osteomalacia, 230 Hruska, 1997, Disorders of phosphorus, calcium, and magnesium metabolism, 2477 1995, HYP Consortium: A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets, Nat Genet, 11, 130, 10.1038/ng1095-130 Inclan, 1943, Tumoral calcinosis, JAMA, 121, 490, 10.1001/jama.1943.02840070018005 Iviker, 1997, Hypophosphatemic vitamin D–resistant rickets, precocious puberty, and the epidermal nevus syndrome, Arch Dermatol, 133, 1557, 10.1001/archderm.1997.03890480077011 Jan de Beur S, Streeten E, Civelek A, et al: Identification of tumors producing oncogenic osteomalacia using somatostatin receptor imaging [abstract P3]. In Proceedings of the 80th Annual Meeting of The Endocrine Society, New Orleans, LA, 1998, p 161 Kay, 1991, Determination of a molecular map position for Hyp using a new interspecific backcross produced by in vitro fertilization, Genomics, 11, 651, 10.1016/0888-7543(91)90072-M Kos, 1994, Localization of a renal sodium-phosphate cotransporter gene to human chromosome 5q35, Genomics, 19, 176, 10.1006/geno.1994.1034 Kozak, 1991, An analysis of vertebrate mRNA sequences: Intimations of translational control, J Cell Biol, 115, 887, 10.1083/jcb.115.4.887 Lajeunesse, 1996, Direct demonstration of a humorally mediated inhibition of renal phosphate transport in the Hyp mouse, Kidney Int, 50, 1531, 10.1038/ki.1996.468 Langman, 1999, Tumoral calcinosis and parathyroid hormone dynamics [abstract], J Bone Miner Res, 14, WG15 Lee, 1986, Intestinal phosphate absorption: Influence of vitamin D and non–vitamin D factors, Am J Physiol, 250, G369 Lipman, 1998, Cloning of human PEX cDNA: Expression, subcellular localization, and endopeptidase activity, J Biol Chem, 273, 13729, 10.1074/jbc.273.22.13729 Lobaugh, 1983, Abnormal regulation of renal 25-hydroxyvitamin D-1 alpha-hydroxylase activity in the X-linked hypophosphatemic mouse, J Clin Invest, 71, 400, 10.1172/JCI110783 Lorenz, 1998, Spermine deficiency in Gy mice caused by deletion of the spermine synthase gene, Hum Mol Genet, 7, 541, 10.1093/hmg/7.3.541 Lyles, 1985, Genetic transmission of tumeral calcinosis: Autosomal dominant with variable clinical expressivity, J Clin Endocrinol Metab, 60, 1093, 10.1210/jcem-60-6-1093 Lyon, 1986, The Gy mutation: Another cause of X-linked hypophosphatemia in mouse, Proc Natl Acad Sci USA, 83, 4899, 10.1073/pnas.83.13.4899 Markowitz, 1981, Circadian rhythms of blood minerals in humans, Science, 213, 672, 10.1126/science.7256269 Massry, 1995, Hypophosphatemia and hyperphosphatemia, 398 Meyer, 1998, Partial deletion of both the spermine synthase gene and the Pex gene in the X-linked hypophosphatemic, Gyro (Gy) mouse, Genomics, 48, 289, 10.1006/geno.1997.5169 Meyer, 1989, Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice, J Bone Miner Res, 4, 493, 10.1002/jbmr.5650040407 Miyauchi, 1988, Hemangiopericytoma-induced osteomalacia: Tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity, J Clin Endocrinol Metab, 67, 46, 10.1210/jcem-67-1-46 Morgan, 1974, Renal transplantation in hypophosphatemia with vitamin D–resistant rickets, Arch Intern Med, 134, 549, 10.1001/archinte.1974.00320210159025 Nelson, 1996, Characteristics of tumor cell bioactivity in oncogenic osteomalacia, Mol Cell Endocrinol, 124, 17, 10.1016/S0303-7207(96)03928-7 Nesbitt, 1992, Crosstransplantation of kidneys in normal and Hyp mice: Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect, Journal of Clinical Investigation, 89, 1453, 10.1172/JCI115735 Nishiyama, 1986, A single case of hypophosphatemic rickets with hypercalciuria, J Pediatr Gastroenterol Nutr, 5, 826, 10.1097/00005176-198609000-00029 Prader, 1959, Rachitis infolge Knochen-tumors, Helv Paediatr Acta, 14, 554 Prince M, Schaefer P, Goldsmith R, et al: Tumoral calcinosis: An ectopic calcification syndrome with elevated serum 1,25-dihydroxycholecalciferol (1,25-(OH)2D3) [abstract 322:235]. In Proceedings of the 60th Annual Meeting of the Endocrine Society, Miami, FL, 1978 Prince, 1982, Hyperphosphatemic tumoral calcinosis: Association with elevation of serum 1,25-dihydroxycholecalciferol concentrations, Ann Intern Med, 96, 586, 10.7326/0003-4819-96-5-586 Proesmans, 1987, Autosomal dominant hypophosphataemia with elevated serum 1,25 dihydroxyvitamin D and hypercalciuria, Pediatr Nephrol, 1, 479, 10.1007/BF00849257 Qiu, 1993, Parental origin of mutant allele does not explain absence of gene dose in X-linked Hyp mice, Genet Res, 62, 39, 10.1017/S0016672300031542 Reed, 1965, Granulomatous (tumoral) calcinosis, Clin Orthop, 43, 233, 10.1097/00003086-196500430-00021 Rizzoli, 1977, Role of 1,25-dihydroxyvitamin D3 on intestinal phosphate absorption in rats with a normal vitamin D supply, J Clin Invest, 60, 639, 10.1172/JCI108815 Rowe, 1996, Candidate 56 and 58 kDa protein(s) responsible for mediating the renal defects in oncogenic hypophosphatemic osteomalacia, Bone, 18, 159, 10.1016/8756-3282(95)00458-0 Ruchon, 1998, Pex mRNA is localized in developing mouse osteoblasts and odontoblasts, J Histochem Cytochem, 46, 459, 10.1177/002215549804600405 Ryan, 1984, Oncogenous osteomalacia: Review of the world literature of 42 cases and report of two new cases, Am J Med, 77, 501, 10.1016/0002-9343(84)90112-8 Scheinman, 1999, Genetic disorders of renal electrolyte transport, N Engl J Med, 340, 1177, 10.1056/NEJM199904153401507 Schurman, 1998, X-linked recessive nephrolithiasis: Presentation and diagnosis in children, J Pediatr, 132, 859, 10.1016/S0022-3476(98)70318-X Scriver, 1977, Hypophosphatemic nonrachitic bone disease: An entity distinct from X-linked hypophosphatemia in the renal defect, bone involvement, and inheritance, Am J Med Genet, 1, 101, 10.1002/ajmg.1320010111 Scriver, 1977, Mendelian phenotypes as “probes” of renal transport systems for amino acids and phosphate Seimon, 1982, Tumoral calcinosis: A surgical problem, J Pediatr Orthop, 2, 409, 10.1097/01241398-198210000-00011 Sonin, 1996, Molecular mapping of the mouse Gy mutation on chromosome X, Mouse Genome, 94, 491 Strom, 1997, Pex gene deletions in Gy and Hyp mice provide mouse models for X-linked hypophosphatemia, Hum Mol Genet, 6, 165, 10.1093/hmg/6.2.165 Tenenhouse, 1997, Cellular and molecular mechanisms of renal phosphate transport, J Bone Miner Res, 12, 159, 10.1359/jbmr.1997.12.2.159 Tenenhouse, 1996, Renal Na(+)-phosphate cotransporter gene expression in X-linked Hyp and Gy mice, Kidney Int, 49, 1027, 10.1038/ki.1996.149 Tenenhouse H, Econs M: Mendelian hypophosphatemias. In Scriver C, Beudet A, Sly W, Valle D (eds): The Metabolic and Molecular Basis of Inherited Disease. New York, McGraw-Hill, in press Tieder, 1992, A new kindred with hereditary hypophosphatemic rickets with hypercalciuria: Implications for correct diagnosis and treatment, Nephron, 62, 176, 10.1159/000187029 Tieder, 1985, Hereditary hypophosphatemic rickets with hypercalciuria, N Engl J Med, 312, 611, 10.1056/NEJM198503073121003 Tieder, 1987, “Idiopathic” hypercalciuria and a hereditary hypophosphatemic rickets: Two phenotypical expressions of a common genetic defect, N Engl J Med, 316, 125, 10.1056/NEJM198701153160302 Vautour, 1998, Renal transplantation does not reverse the metabolic abnormalities associated with X-linked hypophosphatemic rickets [abstract], Bone, 23, S181 Walling, 1977, Intestinal Ca and phosphate transport: Differential responses to vitamin D3 metabolites, Am J Physiol, 233, E488 Walton, 1975, Nomogram for the derivation of renal threshold phosphate concentration, Lancet, 2, 309, 10.1016/S0140-6736(75)92736-1 White, 1998, Refining the autosomal dominant hypophosphatemic rickets (ADHR) interval on chromosome 12p13 and localization of two candidate ADHR genes [abstract], Bone, 23, S379 Whyte, 1996, X-linked hypophosphatemia: A search for gender, race, anticipation, or parent of origin effects on disease expression in children, J Clin Endocrinol Metab, 81, 4075, 10.1210/jc.81.11.4075 Wilson, 1991, Growth hormone therapy in hypophosphatemic rickets, Am J Dis Child, 145, 1165 Winters, 1958, A genetic study of familial hypophosphatemia and vitamin D resistant rickets with a review of the literature, Medicine, 37, 97, 10.1097/00005792-195805000-00001 Yamaguchi, 1995, Successful treatment of hyperphosphatemic tumoral calcinosis with long-term acetazolamide, Bone, 16, 247S, 10.1016/S8756-3282(95)80001-8 Zerwekh, 1980, Tumoral calcinosis: Evidence for concurrent defects in renal tubular phosphorus transport and in 1,25-dihydroxycholecalciferol synthesis, Calcif Tissue Int, 32, 1, 10.1007/BF02408515